Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Manns

Showing results (131-140 of 223) with videos related to

Pageof 23
Sort By:
Hepatology (Baltimore, Md.)|September 1, 1987
Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay and immunoblottingM Manns, G Gerken, A Kyriatsoulis, et al.
Journal of Hepatology|June 12, 1999
The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosisA Tanaka, S Quaranta, A Mattalia, et al.
The Journal of Biological Chemistry|November 5, 1999
p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesisS Kubicka, F Kühnel, L Zender, et al.
Hepatology (Baltimore, Md.)|December 1, 1990
The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosisH Löhr, U Treichel, T Poralla, et al.
The Journal of Biological Chemistry|February 29, 2000
NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitisF Kühnel, L Zender, Y Paul, et al.
Hepatology (Baltimore, Md.)|July 1, 1987
The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in manG Hess, W Gerlich, G Gerken, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 24, 2011
ARFI elastography of the spleen is inferior to liver elastography for the detection of portal hypertensionK Rifai, J Cornberg, M Bahr, et al.
Radiology|December 9, 1998
Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patientsA Chavan, M Galanski, S Wagner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Enhanced bioavailability of cyclosporine using a new oral formulation (Sandimmun optoral) in a liver-grafted patient with severe cholestasisM Winkler, B Ringe, K Schneider, et al.
The American Journal of Gastroenterology|August 1, 1994
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradicationS Wagner, K Haruma, U Gladziwa, et al.
Pageof 23

Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|September 1, 1987
Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay and immunoblottingM Manns, G Gerken, A Kyriatsoulis, et al.
Journal of Hepatology|June 12, 1999
The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosisA Tanaka, S Quaranta, A Mattalia, et al.
The Journal of Biological Chemistry|November 5, 1999
p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesisS Kubicka, F Kühnel, L Zender, et al.
Hepatology (Baltimore, Md.)|December 1, 1990
The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosisH Löhr, U Treichel, T Poralla, et al.
The Journal of Biological Chemistry|February 29, 2000
NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitisF Kühnel, L Zender, Y Paul, et al.
Hepatology (Baltimore, Md.)|July 1, 1987
The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in manG Hess, W Gerlich, G Gerken, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 24, 2011
ARFI elastography of the spleen is inferior to liver elastography for the detection of portal hypertensionK Rifai, J Cornberg, M Bahr, et al.
Radiology|December 9, 1998
Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patientsA Chavan, M Galanski, S Wagner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Enhanced bioavailability of cyclosporine using a new oral formulation (Sandimmun optoral) in a liver-grafted patient with severe cholestasisM Winkler, B Ringe, K Schneider, et al.
The American Journal of Gastroenterology|August 1, 1994
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradicationS Wagner, K Haruma, U Gladziwa, et al.
Pageof 23